Mesa Laboratories Inc (MLAB) - Net Assets
Based on the latest financial reports, Mesa Laboratories Inc (MLAB) has net assets worth $186.69 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($434.85 Million) and total liabilities ($248.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore how efficiently does Mesa Laboratories Inc generate cash to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $186.69 Million |
| % of Total Assets | 42.93% |
| Annual Growth Rate | 14.4% |
| 5-Year Change | -60.66% |
| 10-Year Change | 88.75% |
| Growth Volatility | 24.96 |
Mesa Laboratories Inc - Net Assets Trend (1988–2025)
This chart illustrates how Mesa Laboratories Inc's net assets have evolved over time, based on quarterly financial data. Also explore MLAB total asset value for the complete picture of this company's asset base.
Annual Net Assets for Mesa Laboratories Inc (1988–2025)
The table below shows the annual net assets of Mesa Laboratories Inc from 1988 to 2025. For live valuation and market cap data, see Mesa Laboratories Inc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $159.83 Million | +9.93% |
| 2024-03-31 | $145.39 Million | -63.05% |
| 2023-03-31 | $393.48 Million | -0.08% |
| 2022-03-31 | $393.80 Million | -3.06% |
| 2021-03-31 | $406.23 Million | +84.64% |
| 2020-03-31 | $220.01 Million | +97.66% |
| 2019-03-31 | $111.31 Million | +12.03% |
| 2018-03-31 | $99.36 Million | +1.57% |
| 2017-03-31 | $97.82 Million | +15.52% |
| 2016-03-31 | $84.68 Million | +15.24% |
| 2015-03-31 | $73.48 Million | +14.22% |
| 2014-03-31 | $64.33 Million | +21.95% |
| 2013-03-31 | $52.75 Million | +20.13% |
| 2012-03-31 | $43.91 Million | +20.59% |
| 2011-03-31 | $36.42 Million | +16.73% |
| 2010-03-31 | $31.20 Million | +13.02% |
| 2009-03-31 | $27.60 Million | +16.27% |
| 2008-03-31 | $23.74 Million | +14.55% |
| 2007-03-31 | $20.72 Million | +38.90% |
| 2006-03-31 | $14.92 Million | -2.99% |
| 2005-03-31 | $15.38 Million | -0.03% |
| 2004-03-31 | $15.38 Million | +6.20% |
| 2003-03-31 | $14.49 Million | +4.26% |
| 2002-03-31 | $13.89 Million | +7.43% |
| 2001-03-31 | $12.93 Million | +2.65% |
| 2000-03-31 | $12.60 Million | +5.88% |
| 1999-03-31 | $11.90 Million | +6.25% |
| 1998-03-31 | $11.20 Million | +16.67% |
| 1997-03-31 | $9.60 Million | +20.00% |
| 1996-03-31 | $8.00 Million | +26.98% |
| 1995-03-31 | $6.30 Million | +16.67% |
| 1994-03-31 | $5.40 Million | +22.73% |
| 1993-03-31 | $4.40 Million | +25.71% |
| 1992-03-31 | $3.50 Million | +34.62% |
| 1991-03-31 | $2.60 Million | +52.94% |
| 1990-03-31 | $1.70 Million | +41.67% |
| 1989-03-31 | $1.20 Million | +9.09% |
| 1988-03-31 | $1.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mesa Laboratories Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18673600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $358.54 Million | 224.33% |
| Other Comprehensive Income | $-9.78 Million | -6.12% |
| Total Equity | $159.83 Million | 100.00% |
Mesa Laboratories Inc Competitors by Market Cap
The table below lists competitors of Mesa Laboratories Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mill City Ventures III Ltd
NASDAQ:MCVT
|
$501.70 Million |
|
ARTS Group Co Ltd
SHG:603017
|
$501.96 Million |
|
Zhejiang Tiantai Xianghe Industrial Co Ltd
SHG:603500
|
$502.07 Million |
|
Xinjiang Torch Gas Co Ltd
SHG:603080
|
$502.12 Million |
|
Shanghai Huide Science & Technology Co Ltd
SHG:603192
|
$501.32 Million |
|
Kaufman Et Broad
PA:KOF
|
$501.24 Million |
|
Ehang Holdings Ltd
NASDAQ:EH
|
$501.10 Million |
|
HANGZHOU TIGERMED CO. H 1
F:5HZ1
|
$500.93 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mesa Laboratories Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 145,393,000 to 159,830,000, a change of 14,437,000 (9.9%).
- Net loss of 1,974,000 reduced equity.
- Dividend payments of 3,468,000 reduced retained earnings.
- Other comprehensive income increased equity by 4,980,000.
- Other factors increased equity by 14,899,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.97 Million | -1.24% |
| Dividends Paid | $3.47 Million | -2.17% |
| Other Comprehensive Income | $4.98 Million | +3.12% |
| Other Changes | $14.90 Million | +9.32% |
| Total Change | $- | 9.93% |
Book Value vs Market Value Analysis
This analysis compares Mesa Laboratories Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 287.42x to 3.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1988-03-31 | $0.32 | $90.80 | x |
| 1989-03-31 | $0.48 | $90.80 | x |
| 1990-03-31 | $0.43 | $90.80 | x |
| 1991-03-31 | $0.58 | $90.80 | x |
| 1992-03-31 | $0.82 | $90.80 | x |
| 1993-03-31 | $1.03 | $90.80 | x |
| 1994-03-31 | $1.24 | $90.80 | x |
| 1995-03-31 | $1.52 | $90.80 | x |
| 1996-03-31 | $1.85 | $90.80 | x |
| 1997-03-31 | $2.15 | $90.80 | x |
| 1998-03-31 | $2.55 | $90.80 | x |
| 1999-03-31 | $2.85 | $90.80 | x |
| 2000-03-31 | $3.28 | $90.80 | x |
| 2001-03-31 | $3.47 | $90.80 | x |
| 2002-03-31 | $4.02 | $90.80 | x |
| 2003-03-31 | $4.39 | $90.80 | x |
| 2004-03-31 | $4.90 | $90.80 | x |
| 2005-03-31 | $4.90 | $90.80 | x |
| 2006-03-31 | $4.89 | $90.80 | x |
| 2007-03-31 | $6.41 | $90.80 | x |
| 2008-03-31 | $7.24 | $90.80 | x |
| 2009-03-31 | $8.52 | $90.80 | x |
| 2010-03-31 | $9.47 | $90.80 | x |
| 2011-03-31 | $10.94 | $90.80 | x |
| 2012-03-31 | $12.68 | $90.80 | x |
| 2013-03-31 | $14.68 | $90.80 | x |
| 2014-03-31 | $17.82 | $90.80 | x |
| 2015-03-31 | $20.13 | $90.80 | x |
| 2016-03-31 | $22.54 | $90.80 | x |
| 2017-03-31 | $25.45 | $90.80 | x |
| 2018-03-31 | $26.36 | $90.80 | x |
| 2019-03-31 | $27.60 | $90.80 | x |
| 2020-03-31 | $50.33 | $90.80 | x |
| 2021-03-31 | $79.28 | $90.80 | x |
| 2022-03-31 | $73.81 | $90.80 | x |
| 2023-03-31 | $73.40 | $90.80 | x |
| 2024-03-31 | $26.99 | $90.80 | x |
| 2025-03-31 | $29.44 | $90.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mesa Laboratories Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.24%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.82%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 2.71x
- Recent ROE (-1.24%) is below the historical average (9.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1989 | 8.33% | 9.09% | 0.79x | 1.17x | $-20.00K |
| 1990 | 23.53% | 14.29% | 1.12x | 1.47x | $230.00K |
| 1991 | 34.62% | 25.71% | 1.09x | 1.23x | $640.00K |
| 1992 | 25.71% | 23.68% | 0.93x | 1.17x | $550.00K |
| 1993 | 20.45% | 20.45% | 0.81x | 1.23x | $460.00K |
| 1994 | 18.52% | 16.13% | 1.02x | 1.13x | $460.00K |
| 1995 | 19.05% | 18.18% | 0.96x | 1.10x | $570.00K |
| 1996 | 20.00% | 19.75% | 0.92x | 1.10x | $800.00K |
| 1997 | 17.71% | 21.79% | 0.76x | 1.06x | $740.00K |
| 1998 | 18.75% | 26.58% | 0.67x | 1.05x | $980.00K |
| 1999 | 17.65% | 25.93% | 0.64x | 1.06x | $910.00K |
| 2000 | 16.72% | 24.34% | 0.64x | 1.07x | $846.67K |
| 2001 | 14.17% | 20.13% | 0.66x | 1.07x | $538.97K |
| 2002 | 14.62% | 22.46% | 0.63x | 1.04x | $641.52K |
| 2003 | 14.68% | 23.42% | 0.60x | 1.05x | $678.23K |
| 2004 | 13.85% | 23.34% | 0.56x | 1.05x | $591.60K |
| 2005 | 15.03% | 23.03% | 0.61x | 1.08x | $774.10K |
| 2006 | 18.80% | 24.22% | 0.70x | 1.10x | $1.31 Million |
| 2007 | 19.10% | 22.96% | 0.77x | 1.08x | $1.89 Million |
| 2008 | 19.42% | 23.57% | 0.77x | 1.08x | $2.24 Million |
| 2009 | 17.35% | 22.24% | 0.73x | 1.07x | $2.03 Million |
| 2010 | 15.29% | 21.75% | 0.65x | 1.08x | $1.65 Million |
| 2011 | 16.98% | 18.84% | 0.64x | 1.40x | $2.54 Million |
| 2012 | 18.03% | 19.99% | 0.78x | 1.15x | $3.53 Million |
| 2013 | 16.02% | 18.20% | 0.70x | 1.25x | $3.17 Million |
| 2014 | 13.99% | 17.07% | 0.54x | 1.52x | $2.57 Million |
| 2015 | 13.04% | 13.43% | 0.61x | 1.60x | $2.24 Million |
| 2016 | 13.19% | 13.19% | 0.53x | 1.90x | $2.70 Million |
| 2017 | 11.43% | 11.94% | 0.55x | 1.76x | $1.40 Million |
| 2018 | -2.98% | -3.08% | 0.59x | 1.65x | $-12.90 Million |
| 2019 | 6.72% | 7.26% | 0.66x | 1.41x | $-3.65 Million |
| 2020 | 0.81% | 1.51% | 0.28x | 1.91x | $-20.22 Million |
| 2021 | 0.81% | 2.44% | 0.22x | 1.48x | $-37.35 Million |
| 2022 | 0.48% | 1.01% | 0.26x | 1.80x | $-37.51 Million |
| 2023 | 0.24% | 0.42% | 0.33x | 1.68x | $-38.42 Million |
| 2024 | -174.87% | -117.60% | 0.48x | 3.07x | $-268.79 Million |
| 2025 | -1.24% | -0.82% | 0.56x | 2.71x | $-17.96 Million |
Industry Comparison
This section compares Mesa Laboratories Inc's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $297,704,384
- Average return on equity (ROE) among peers: -32.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mesa Laboratories Inc (MLAB) | $186.69 Million | 8.33% | 1.33x | $501.65 Million |
| Ainos Inc (AIMD) | $-3.37 Million | 0.00% | 0.00x | $12.35 Million |
| Arrive AI Inc. (ARAI) | $-477.77K | 0.00% | 0.00x | $30.21 Million |
| Arbe Robotics Ltd (ARBE) | $42.09 Million | -103.34% | 0.20x | $98.24 Million |
| Astrotech Corp (ASTC) | $2.71 Million | -278.21% | 0.36x | $4.87 Million |
| Badger Meter Inc (BMI) | $144.46 Million | 23.65% | 0.32x | $3.66 Billion |
| Cognex Corporation (CGNX) | $825.67 Million | 22.66% | 0.08x | $10.93 Billion |
| Coherent Inc (COHR) | $900.56 Million | 10.58% | 0.64x | $65.59 Billion |
| Electro-Sensors Inc (ELSE) | $12.32 Million | 1.64% | 0.06x | $26.95 Million |
| ESCO Technologies Inc (ESE) | $1.02 Billion | 6.23% | 0.55x | $7.01 Billion |
| FARO Technologies Inc (FARO) | $33.38 Million | -6.04% | 0.35x | $849.75 Million |
About Mesa Laboratories Inc
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and clean… Read more